Cost-Effectiveness Analysis of Infrapopliteal Drug-Eluting Stents

@article{Katsanos2012CostEffectivenessAO,
  title={Cost-Effectiveness Analysis of Infrapopliteal Drug-Eluting Stents},
  author={Konstantinos Katsanos and Dimitris Karnabatidis and Athanassios Diamantopoulos and Stavros Spiliopoulos and Dimitris Siablis},
  journal={CardioVascular and Interventional Radiology},
  year={2012},
  volume={36},
  pages={90-97}
}
There are no cost-utility data about below-the-knee placement of drug-eluting stents. The authors determined the cost-effectiveness of infrapopliteal drug-eluting stents for critical limb ischemia (CLI) treatment. The event-free individual survival outcomes defined by the absence of any major events, including death, major amputation, and target limb repeat procedures, were reconstructed on the basis of two published infrapopliteal series. The first included spot Bail-out use of Sirolimus… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 23 references

Similar Papers

Loading similar papers…